Pages that link to "Q57210536"
Jump to navigation
Jump to search
The following pages link to Pier Vitale Nuzzo (Q57210536):
Displaying 20 items.
- Periostin: a novel prognostic and therapeutic target for genitourinary cancer? (Q30360525) (← links)
- Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature. (Q34123665) (← links)
- Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death (Q34526920) (← links)
- Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery (Q35637149) (← links)
- The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome (Q35922746) (← links)
- Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa) (Q36088433) (← links)
- Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines. (Q39182097) (← links)
- Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials. (Q47162505) (← links)
- Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report. (Q53477708) (← links)
- Prognostic value of nuclear matrix protein expression in localized prostate cancer (Q83841923) (← links)
- A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer (Q89128851) (← links)
- Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma (Q89747242) (← links)
- Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study (Q90690141) (← links)
- Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors (Q90803091) (← links)
- Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma (Q90949356) (← links)
- Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome (Q91253745) (← links)
- Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma (Q92025206) (← links)
- Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors (Q93161780) (← links)
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes (Q96641385) (← links)
- Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes (Q99207831) (← links)